Abstract
Invasive fungal infections, especially candidiasis and aspergillosis, are a major cause of morbidity and mortality. Many controversies surround the management of these infections. A critical overview of the recent Infectious Diseases Society of America practice guidelines is provided, as are comments on both the conundrums and future perspectives in medical mycology.
Original language | English (US) |
---|---|
Pages (from-to) | 175S-187S |
Journal | Pharmacotherapy |
Volume | 21 |
Issue number | 8 SUPPL. 2 |
DOIs | |
State | Published - 2001 |
ASJC Scopus subject areas
- Pharmacology (medical)